Brain Cancer
News and reporting on brain cancer.
Biotech firms are engineering smarter, safer gene delivery systems to enhance the safety and efficacy of genetic medicines.
The firm is using single-cell, multiomics analysis to probe tumor samples from very long-term cancer survivors for keys to defeating the disease.
Denovo, Anova Begin Brain Cancer Gene Therapy Trial Involving Response Biomarker
In an earlier study, patients with biomarker-positive high-grade glioma lived longer after treatment with DB107 than biomarker-negative patients.
FDA Grants Priority Review to Chimerix for Dordaviprone in H3 K27M-Mutant Diffuse Glioma
In a Phase III trial, 28 percent of newly diagnosed patients with H3 K27M-mutant diffuse glioma responded to treatment with dordaviprone.
BrainChild Bio Pursuing Pivotal Trial of CAR T Therapy in Pediatric Brain Cancer
The firm has discussed positive Phase I results on BCB-276 with the FDA and plans to move it directly to a registrational trial by year-end.